Candel Therapeutics Insider Ups Holding By 14% During Year
An insider at Candel Therapeutics increased their holdings by 14% over the past year, as reported by recent SEC filings. This significant increase in ownership by a company insider could be seen as a positive signal to investors, indicating confidence in the company's future …